Details for New Drug Application (NDA): 003977
✉ Email this page to a colleague
NDA 003977 describes THEELIN, which is a drug marketed by Parkedale and is included in one NDA. Additional details are available on the THEELIN profile page.
The generic ingredient in THEELIN is estrone. There are nine drug master file entries for this compound. Additional details are available on the estrone profile page.
The generic ingredient in THEELIN is estrone. There are nine drug master file entries for this compound. Additional details are available on the estrone profile page.
Medical Subject Heading (MeSH) Categories for 003977
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
